ISSN:1173-8324    

出版商:ADIS    

年代:1998

数据来源: ADIS

ISSN:1173-8324    

出版商:ADIS    

年代:1998

数据来源: ADIS

ISSN:1173-8324    

出版商:ADIS    

年代:1998

数据来源: ADIS

摘要:

The cost of treatment is of considerable interest to all those involved in caring for patients with schizophrenia. In a real-life setting, the atypical antipsychotic risperidone was more cost effective than olanzapine in the treatment of this expensive psychiatric disorder, according to a drug utilisation review conducted within a tertiary-care facility in British Columbia, Canada. These new data were presented at the 21st Congress of the Collegium Internationale Neuropsychopharmacologicum (CINP) [Glasgow, Scotland; July 1998].

ISSN:1173-8324    

出版商:ADIS    

年代:1998

数据来源: ADIS

ISSN:1173-8324    

出版商:ADIS    

年代:1998

数据来源: ADIS

ISSN:1173-8324    

出版商:ADIS    

年代:1998

数据来源: ADIS

摘要:

Glycoprotein (GP) IIb/IIIa receptor antagonists work by blocking the final common pathway of platelet aggregation, and are considered to be the most potent antiplatelet drugs available to date. Their use in patients with acute coronary syndromes was a common theme interspersed through many of the sessions at the 20th Congress of the European Society of Cardiology [Vienna, Austria; August 1998]. At present, GP IIb/IIIa receptor antagonists are only available for IV inpatient use. Development of these agents as an oral therapy would allow administration for a longer period of time which may be more suitable for use in the long-term prevention of coronary thrombosis, delegates were told.

ISSN:1173-8324    

出版商:ADIS    

年代:1998

数据来源: ADIS

ISSN:1173-8324    

出版商:ADIS    

年代:1998

数据来源: ADIS

ISSN:1173-8324    

出版商:ADIS    

年代:1998

数据来源: ADIS

ISSN:1173-8324    

出版商:ADIS    

年代:1998

数据来源: ADIS